Jon Yu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jon Yu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jon Yu Today - Breaking & Trending Today

Vaxxinity's Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published -February 15, 2024 at 08:02 am EST

Published: February 15, 2024

Preclinical data published in the Journal of Lipid Research indicate VXX-401 is well-tolerated, with no safety signals observed, and robustly reduces LDL-C in cynomolgus monkeys. A Phase 1 trial of...

Source: marketscreener.com

Related Topics:

Mark Joinnides Jon Yu Vaxxinity Inc Exchange Commission On World Health Organization Journal Of Lipid Research Volume Journal Of Lipid Research Lipid Research Private Securities Litigation Reform Act Annual Report Exchange Commission World Health Clinical Outcomes Cardiovascular Outcomes Acute Coronary

Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference

Published: January 3, 2024

CAPE CANAVERAL, Fla., Jan. 03, 2024 -- Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of medicines, today announced that Mei Mei Hu, Chief Executive Officer of...

Source: marketscreener.com

Related Topics:

Mark Joinnides Jon Yu Exchange Commission On Vaxxinity Inc Chief Executive Officer Healthcare Conference Private Securities Litigation Reform Act Annual Report Exchange Commission

Comera Life Sciences Appoints Dorothy Clarke to Board of

Published: November 13, 2023

WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new...

Source: globenewswire.com

Related Topics:

Jeffrey Hackman Comera Sqore Jon Yu Dorothy Clarke John Woolford Company Annual Report On Form Comera Life Sciences Holdings Inc Comera Life Sciences Life Sciences Holdings Chief Executive Officer Nasdaq Capital Market Annual Report Nasdaq Cmra Comera Life Sciences

Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Published: November 8, 2023

CAPE CANAVERAL, Fla., Nov. 08, 2023 -- Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of medicines, today reported financial results for the third quarter ended...

Source: marketscreener.com

Related Topics:

United Kingdom Jon Yu Sumita Ray Peter Powchik Mark Joinnides Drug Administration Exchange Commission On Vaxxinity Inc Michaelj Fox Foundation Executive Vice President Global Scientific Director Chief Legal Fast Track Designation Private Securities Litigation Reform Act Annual Report Exchange Commission